| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,622 |
21,284 |
$7.58M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,778 |
4,471 |
$1.89M |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
14,481 |
13,837 |
$866K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,786 |
14,816 |
$693K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,235 |
6,593 |
$369K |
| 71045 |
Radiologic examination, chest; single view |
11,225 |
10,482 |
$357K |
| 80053 |
Comprehensive metabolic panel |
25,879 |
22,801 |
$303K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,361 |
6,019 |
$273K |
| 59025 |
Fetal non-stress test |
1,808 |
1,427 |
$250K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,170 |
23,794 |
$228K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13,142 |
12,543 |
$217K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
76 |
75 |
$212K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13,813 |
13,102 |
$200K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
171 |
168 |
$90K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,025 |
956 |
$82K |
| 42830 |
|
44 |
44 |
$58K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,059 |
267 |
$55K |
| 81001 |
|
15,909 |
14,490 |
$54K |
| 84702 |
|
5,216 |
4,565 |
$52K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,280 |
1,211 |
$50K |
| 83690 |
|
6,582 |
5,970 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,391 |
1,189 |
$30K |
| 84112 |
|
230 |
190 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,019 |
972 |
$21K |
| 84484 |
|
3,472 |
3,012 |
$21K |
| 93975 |
|
149 |
120 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
373 |
352 |
$18K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
358 |
340 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
502 |
453 |
$14K |
| 86850 |
|
932 |
875 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
448 |
418 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
23,205 |
19,966 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
24 |
24 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
851 |
699 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,472 |
1,367 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
143 |
106 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
753 |
648 |
$8K |
| 84703 |
|
1,218 |
1,130 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
453 |
367 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
89 |
86 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
287 |
246 |
$5K |
| 83880 |
|
1,021 |
930 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
757 |
626 |
$4K |
| 84145 |
|
469 |
449 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
72 |
63 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
270 |
257 |
$3K |
| 83605 |
|
1,148 |
1,017 |
$3K |
| 87653 |
|
81 |
72 |
$3K |
| 85027 |
|
394 |
363 |
$3K |
| 86900 |
|
1,232 |
1,127 |
$3K |
| 86901 |
|
1,230 |
1,125 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
186 |
186 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
632 |
586 |
$2K |
| 87081 |
|
241 |
228 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
359 |
325 |
$2K |
| 86592 |
|
381 |
354 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
44 |
39 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,736 |
3,864 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,112 |
1,000 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$2K |
| 86780 |
|
98 |
92 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
88 |
75 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
12 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,420 |
1,423 |
$1K |
| 85610 |
|
1,067 |
964 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
17 |
15 |
$1K |
| 36416 |
|
612 |
564 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
21 |
17 |
$1K |
| 83735 |
|
779 |
585 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
43 |
36 |
$1K |
| 80061 |
Lipid panel |
54 |
52 |
$1K |
| 76801 |
|
14 |
12 |
$1K |
| 85730 |
|
624 |
565 |
$1K |
| 0001A |
|
225 |
200 |
$1K |
| 87210 |
|
114 |
98 |
$957.32 |
| 99215 |
Prolong outpt/office vis |
45 |
40 |
$920.16 |
| 0002A |
|
215 |
176 |
$818.96 |
| 0071A |
|
54 |
54 |
$677.79 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
825 |
730 |
$644.50 |
| 86140 |
|
263 |
248 |
$518.24 |
| 82950 |
|
79 |
77 |
$479.48 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
165 |
147 |
$479.36 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
13 |
$466.11 |
| 96160 |
|
65 |
63 |
$463.76 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
29 |
29 |
$450.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
365 |
332 |
$431.21 |
| 87340 |
|
26 |
24 |
$425.16 |
| 86803 |
|
28 |
25 |
$396.94 |
| 82803 |
|
104 |
93 |
$348.22 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
15 |
12 |
$328.91 |
| 0072A |
|
28 |
28 |
$317.87 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
961 |
851 |
$306.21 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
678 |
421 |
$294.61 |
| 86762 |
|
12 |
12 |
$287.75 |
| 94760 |
|
35 |
26 |
$257.34 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
13 |
$182.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
460 |
300 |
$180.18 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$154.32 |
| 82570 |
|
14 |
13 |
$129.81 |
| 84156 |
|
15 |
14 |
$91.89 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
17 |
$72.00 |
| 85007 |
|
38 |
35 |
$66.99 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
30 |
25 |
$63.19 |
| 81003 |
|
55 |
50 |
$62.28 |
| 87186 |
|
33 |
29 |
$29.08 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
142 |
127 |
$24.97 |
| 96161 |
|
201 |
169 |
$18.28 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
65 |
53 |
$14.33 |
| J7510 |
Prednisolone oral, per 5 mg |
36 |
35 |
$12.86 |
| 82962 |
|
782 |
560 |
$7.78 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
12 |
12 |
$3.84 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,868 |
2,840 |
$0.03 |
| J2704 |
Injection, propofol, 10 mg |
232 |
135 |
$0.00 |